Staurosporine derivatives as inhibitors of FLT3 receptor tyrosine kinase activity
A Standard patent application filed on 29 October 2002 credited to Manley, Paul William ; Griffin, James Douglas

Details

Application number :

2002357992  

Application type :

Standard  

Application status :

LAPSED  

Under opposition :

No  

Proceeding type :

 

Invention title :

Staurosporine derivatives as inhibitors of FLT3 receptor tyrosine kinase activity  

Inventor :

Manley, Paul William ; Griffin, James Douglas  

Agent name :

Davies Collison Cave  

Address for service :

1 Nicholson Street Melbourne VIC 3000 Australia  

Filing date :

29 October 2002  

Associated companies :

 

Applicant name :

Novartis AG  

Applicant address :

Lichstrasse 35 Basle CH-4056 Switzerland  

Old name :

 

Original Source :

Go